Using a new process, scientists can create new nucleoside analogs months earlier than with the previous method, paving the way for quicker drug discoveries
Revolutionary approaches to drug discovery aided by informatics and guided toward precision medicine have helped bring new drug approvals back to pre-1996 levels
The Aigenpulse platform harnesses the latest artificial intelligence and machine learning tools to deliver advanced analytics to underpin scientific decision making
Four promising antiviral drug candidates have been identified and analyzed by a University of Arizona-University of South Florida team in a preclinical study